J-L. Pujol

LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

Tina Cascone, Mark M. Awad, J.D. Spicer et al. · Annals of Oncology · 2023 · 100 citations · Full text

Medicine, Oncology, Pharmacology +12

Identification of an Alveolar Macrophage-derived Activity in Bronchial Asthma that Enhances Leukotriene C4 Generation by Human Eosinophils Stimulated by lonophore A23187 as a Granulocyte-macrophage Colony-stimulating Factor

C. J. Howell, J-L. Pujol, Attilio Crea et al. · American Review of Respiratory Disease · 1989 · 94 citations

Life Sciences, Immunology, Pharmacology +13

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO* analysis of prognostic factors

William Jacot, Xavier Quantin, Fabrice André et al. · British Journal of Cancer · 2001 · 73 citations · Full text

Medicine, Oncology, Metastasis +12

Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer

Xavier Quantin, Farid Khial, M. Reme-Saumon et al. · Lung Cancer · 1999 · 31 citations

Medicine, Oncology, Radiation Oncology +13

OA08.05 Tusamitamab Ravtansine vs Docetaxel in Previously Treated Advanced Nonsquamous NSCLC: Results from Phase 3 CARMEN-LC03 Trial

B. Besse, Giuseppe Lo Russo, H. Léna et al. · Journal of Thoracic Oncology · 2024 · 23 citations · Full text

Medicine, Oncology, Pharmacology +3